Sagona Europe Equity SCSp focus on seed and early-stage purpose-driven companies with modern approaches to established leaders expanding into new markets. We aim to invest in companies that address economic needs in potential new markets created by technological advancements.
We seek device or technology which create a new treatment modality or represent a substantial improvement. The companies must have a business model that provides a sustainable advantage, the potential to serve a significant addressable global market with a robust intellectual property protection resulting in potential breakthrough therapies and must fit an area of strategic need for potential acquirers.
Sagona Europe Equity SCSp brings more than just capital. We act as a true value-added investor and support companies in achieving value-creating milestones. Through our USA-Europe bridge and our extended network, we work closely with the companies by providing operational, regulatory, commercial, administrative and clinical expertise driven by the support of key opinion leaders in the scientific communities.
Our mission is also supported by a dedicated team of advisors who have access to a broad network within academic, finance and various industris providing insight and guidance to companies. We take an active role in the business development of our companies.